Clinical trials
Carcinoma, Non-Small-Cell Lung trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
634 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 14 |
| 2007 | 13 |
| 2008 | 21 |
| 2009 | 19 |
| 2010 | 16 |
| 2011 | 18 |
| 2012 | 18 |
| 2013 | 19 |
| 2014 | 27 |
| 2015 | 36 |
| 2016 | 24 |
| 2017 | 34 |
| 2018 | 37 |
| 2019 | 47 |
| 2020 | 45 |
| 2021 | 45 |
| 2022 | 45 |
| 2023 | 38 |
| 2024 | 46 |
| 2025 | 33 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 267 |
| Active, not recruiting | 126 |
| Recruiting | 93 |
| Terminated | 75 |
| Unknown status | 62 |
| Withdrawn | 3 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Available | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 62 |
| Hoffmann-La Roche | 41 |
| Novartis Pharmaceuticals | 37 |
| Merck Sharp & Dohme LLC | 34 |
| Eli Lilly and Company | 32 |
| Samsung Medical Center | 28 |
| Pfizer | 27 |
| Yonsei University | 20 |
| Boehringer Ingelheim | 17 |
| Bristol-Myers Squibb | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 634 |
| Lung Neoplasms | 113 |
| Neoplasms | 76 |
| Neoplasm Metastasis | 52 |
| Colorectal Neoplasms | 42 |
| Breast Neoplasms | 28 |
| Squamous Cell Carcinoma of Head and Neck | 27 |
| Pancreatic Neoplasms | 26 |
| Stomach Neoplasms | 25 |
| Carcinoma | 24 |
Trials
Showing 26 to 50 of 634. Each trial links to its page on Pharma Observatory.
534 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.